COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting
28/03/2018
RANCHO CORDOVA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) today announced that two late-breaking abstracts involving the use of Cesca’s X-Series™ technologies for cell [...]
Aileron Therapeutics Announces Expansion of Scientific Advisory Board
28/03/2018
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that [...]
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting
28/03/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces that it has been selected for an Emerging Science dual oral and poster [...]
Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
28/03/2018
CALGARY, Alberta, March 28, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today the publication of two new articles on the effect of apabetalone, a novel small [...]
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results
28/03/2018
CHARLESTON, S.C., March 28, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today reported financial and operating results for the fourth quarter and year ended December 31, 2017. All Amounts [...]
Hiku Brands and dosist join forces in Canadian market
28/03/2018
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU), Canada’s first vertically-integrated cannabis brand house, is pleased to announce it has entered into a letter of intent to [...]
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging
28/03/2018
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging Lille (France), Cambridge (Massachusetts, United States [...]
GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning
28/03/2018
GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning Lille (France), [...]
Hydropothecary reports fiscal 2018 second quarter results; achieves revenue visibility and business certainty for the first year following cannabis legalization
28/03/2018
GATINEAU, Quebec, March 28, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX VENTURE:THCX) (the "Company") reported its financial results for the three and six months ended January 31, 2018, the second [...]
Hydropothecary déclare les résultats du deuxième trimestre de l’exercice 2018, démontrant la prévisibilité de ses revenus et sa certitude commerciale dès la première année suivant la légalisation du cannabis
28/03/2018
GATINEAU, Quebec, 28 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (la « Société ») a publié ses résultats financiers pour le trimestre et le semestre clos le 31 janvier 2018, à savoir le [...]
PotNetwork Holding Inc.’s Diamond CBD Releases Corporate Video Highlighting Consumer Response to its Natural Health and Wellness Products
28/03/2018
FT LAUDERDALE, Fla., March 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On Wednesday, March 28th, 2018, PotNetwork Holding Inc.’s wholly owned subsidiary, Diamond CBD Inc. [...]
Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress™ (EASL)
28/03/2018
INDIANAPOLIS and SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018
28/03/2018
Company announcement, Helsinki, 28 March 2018, at 12 PM Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted [...]
Enzymatica AB: Enzymatica - publication of the annual report 2017
28/03/2018
Press release Lund, 28 march 2018 Enzymatica - publication of the annual report 2017 Enzymatica announces today that the annual report 2017 is available on the company's web site www.enzymatica.se . The annual report is [...]
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28/03/2018
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first [...]
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
28/03/2018
Basel, March 28, 2018 - Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
28/03/2018
REGULATED INFORMATION GHENT, Belgium, 28 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Kiadis Pharma on track with European regulatory review for ATIR101
28/03/2018
Kiadis Pharma on track with European regulatory review for ATIR101 Responses submitted to EMA Day 120 list of questions Amsterdam, The Netherlands, March 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company [...]
Arcturus Therapeutics Initiates Lawsuit Against Joseph E. Payne to Protect the Interests of Arcturus Shareholders
28/03/2018
Complaint Details Extensive Misconduct by Mr. Payne during Tenure as CEO Cites Mr. Payne’s Self-Dealing and Inappropriate Business Conflicts of Interest SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Arcturus [...]

Pages